LC4 Consulting is a boutique agency fully focusing on supporting early products and programs in early development, including Business Development Programs. We are offering a breath of experience in a wide range of immunotherapies, auto-immune compounds and biologics in the cancer settings, eg. monoclonal antibodies, Andtibody Drug Conjugates (ADC), and cell based cancer vaccines.
Guidance on the SOP for commercialization of early compounds and the required deliverables per development stage (Ph1-2-3).
A systematic strategic analysis of the disease landscape provides the foundation for entering a new therapeutic area.
A key list of cross-functional questions drives the cross-functional alignment on defining the optimal value, pricing and reimbursement of the program.
Development of the cross-functional recommendations for improving the differentiation strategy and increasing the value proposition.